Free tool
FAERS Monitor: Lifyorli (Copackaged)
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 220641 or its brand name (Lifyorli (Copackaged), Relacorilant). Reports on generic versions are filed under their own applications.
Reports
99
Serious
71
72% of reports
Hospitalization
51
Death reported
22
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- neutropenia13
- death12
- nausea12
- stomatitis11
- vomiting10
- diarrhoea9
- fatigue7
- pneumonia6
- ascites5
- mucosal inflammation5
- dehydration4
- off label use4
- pancytopenia4
- acute respiratory failure3
- anaemia3
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2025 | 1 |
| 2026 | 96 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,060 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| mucosal inflammationSignal | 5 | 40.6 | 17.3 | 156 |
| stomatitisSignal | 11 | 38.5 | 22.1 | 367 |
| ascitesSignal | 5 | 36.1 | 15.4 | 138 |
| acute respiratory failureSignal | 3 | 33.1 | 10.9 | 64 |
| neutropeniaSignal | 13 | 20.3 | 12.2 | 221 |
| pancytopeniaSignal | 4 | 15.2 | 5.8 | 40 |
| dehydrationSignal | 4 | 6.4 | 2.4 | 13 |
| vomitingSignal | 10 | 4.5 | 2.5 | 25 |
| pneumoniaSignal | 6 | 3.9 | 1.8 | 11 |
| anaemia | 3 | 3.3 | 1.1 | 3 |
| nauseaSignal | 12 | 3.2 | 1.9 | 17 |
| diarrhoeaSignal | 9 | 3.0 | 1.6 | 10 |
| deathSignal | 12 | 3.0 | 1.7 | 14 |
| fatigue | 7 | 1.9 | 0.9 | 2 |
| off label use | 4 | 1.0 | 0.4 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.